MR
Moderna
MRNA · NASDAQ
$145.55 -4.87% (-$7.45)
1M +145.99%
Market Cap $59.1B
P/E Ratio -
Div. Yield -
ROE 39.21%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.74x
P/S 26.51x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 23.24%
Rev. growth 53.13%
FCF growth N/A
Profitability
0 /100
Weak Net margin 141.43%
Op. margin 149.01%
FCF margin 54.89%
Quality
3 /100
Poor ROE 39.21%
ROA 28.75%
Asset turnover 0.20x
Debt
69 /100
Low Current ratio 2.29x
Int. coverage -122.80x
Debt/Equity 0.19x
Stability
50 /100
Moderate Rev. volatility 12.29%
EPS volatility 106.63%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MRNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stéphane Bancel
Employees
4,700
Headquarters
Cambridge
Nadcházející události
05 LIS
Earnings
Upcoming earnings report